product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Bub1b Antibody
catalog :
4116
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
citations: 1
Reference
Fu X, Chen G, Cai Z, Wang C, Liu Z, Lin Z, et al. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. Onco Targets Ther. 2016;9:2211-20 pubmed publisher
product information
SKU :
4116S
Product-Name :
Bub1b Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
130
Host :
Rabbit
Target :
Bub1B
Primary-Protein :
BubR1
Alt-Names :
BUB1B,BUB1beta,BUBR1,Bub1A,MAD3/BUB1-related protein kinase,MAD3L,Mitotic checkpoint kinase MAD3L,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta,Protein SSK1,SSK1,budding uninhibited by benzimidazoles 1 homolog beta (yeast),hBUBR1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.